We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This document contains a synopsis of causation occurring in migraine.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Norgine Limited is recalling one batch of product as a precautionary measure due to some units containing low amounts of active ingredients.
Public health principles for reducing the spread of respiratory infections, including COVID-19, in the workplace.
As with any medicine, the MHRA will keep the safety and effectiveness of concizumab under close review.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).